Ex-Heritage Pharma Execs Settle Price-Fixing Case

May 25, 2017

Reuters

Two executives who were employed by Heritage Pharmaceuticals and pleaded guilty to fixing drug prices earlier this year have agreed to settle with 41 states and territories involved in the probe, according to a Reuters article.

Jason Malek, former president of Heritage Pharma, and Jeffrey Glazer, former chairman and CEO, agreed to cooperate in the state probe and each will pay a $25,000 civil penalty, according to the office of Connecticut Attorney General George Jepsen.

Heritage is a subsidiary of Emcure Ltd.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments